Caisson, Novo in drug delivery deal

Caisson Biotech LLC granted Novo Nordisk A/S (CSE:NVO; NYSE:NVO) exclusive, worldwide rights to use heparosan-based drug delivery technology to engineer and develop compounds within undisclosed indica...